prikaz prve stranice dokumenta Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy
  Preuzmi
PDF 2.18 MB
Znanstveni rad - Izvorni znanstveni rad
Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy
Clinical Medicine, 7 (2018), 9; 1-12. https://doi.org/10.3390/jcm7090287
Bojanić, Kristina; Bilić Čurčić, Ines; Kuna, Lucija; Kizivat, Tomislav; Smolić, Robert; Raguž Lučić, Nikola; Kralik, Kristina; Šerić, Vatroslav; Ivanac, Gordana; Tucak-Zorić, Sandra; Včev, Aleksandar; Smolić, Martina

Institucijski repozitorij: Repozitorij KBC Osijek

Citirajte ovaj rad

Bojanić, K., Bilić Čurčić, I., Kuna, L., Kizivat, T., Smolić, R., Raguž Lučić, N. ... Smolić, M. (2018). Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy. Clinical Medicine, 7. (9), 1-12. doi: 10.3390/jcm7090287

Bojanić, Kristina, et al. "Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy." Clinical Medicine, vol. 7, br. 9, 2018, str. 1-12. https://doi.org/10.3390/jcm7090287

Bojanić, Kristina, Ines Bilić Čurčić, Lucija Kuna, Tomislav Kizivat, Robert Smolić, Nikola Raguž Lučić, Kristina Kralik, et al. "Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy." Clinical Medicine 7, br. 9 (2018): 1-12. https://doi.org/10.3390/jcm7090287

Bojanić, K., et al. (2018) 'Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy', Clinical Medicine, 7(9), str. 1-12. doi: 10.3390/jcm7090287

Bojanić K, Bilić Čurčić I, Kuna L, Kizivat T, Smolić R, Raguž Lučić N, i sur.. Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy. Clinical Medicine [Internet]. 2018. [pristupljeno 12.05.2024.];7(9):1-12. doi: 10.3390/jcm7090287

K. Bojanić, et al., "Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy", Clinical Medicine, vol. 7, br. 9, str. 1-12, 2018. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:239:315693. [Citirano: 12.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:239:315693
Podaci o radu
Naslov (engleski)Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy
AutorKristina Bojanić
MBZ: 272625
AutorInes Bilić Čurčić
MBZ: 268184
AutorLucija Kuna
MBZ: 353546
AutorTomislav Kizivat
MBZ: 302955
AutorRobert Smolić
MBZ: 292166
AutorNikola Raguž Lučić
MBZ: 350405
AutorKristina Kralik
AutorVatroslav Šerić
MBZ: 193563
AutorGordana Ivanac
MBZ: 277952
AutorSandra Tucak-Zorić
MBZ: 320540
AutorAleksandar Včev
MBZ: 141721
AutorMartina Smolić
MBZ: 292155
Autorova ustanova(Klinički bolnički centar Osijek)
Autorova ustanovaSveučilište Josipa Jurja Strossmayera u Osijeku
Medicinski fakultet Osijek
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Onkologija
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Farmakologija
Sažetak (engleski)
AIM: To determine the levels of Wnt inhibitors in patients treated with aromatase inhibitors (AIs) prior to therapy and to investigate their association with bone mineral density (BMD) and lifestyle parameters. METHODS: 137 breast cancer patients were divided into a group treated with 1 mg of anastrozole and a group w/o anastrozole therapy. Serum concentrations of sclerostin and dickkopf1 (DKK1) were measured by ELISA. BMD was measured by dual-energy X-ray absorptiometry (DXA). Lifestyle factors were investigated by a self-reported questionnaire. RESULTS: Sclerostin was significantly higher in the AI-treated group (31.8 pmol/L vs. 24.1 pmol/L; p < 0.001), whereas DKK1 was significantly lower in the AI-treated group (24.3 pmol/L vs. 26.02 pmol/L; p < 0.001). Total hip and femoral neck BMD were significantly lower in the AI-treated group. CONCLUSION: AI treatment was associated with increased levels of sclerostin and decreased levels of DKK1.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaClinical Medicine
Brojčani podacivol. 7, br. 9, str. 1-12
p-ISSN1470-2118
e-ISSN1473-4893
DOIhttps://doi.org/10.3390/jcm7090287
URN:NBNurn:nbn:hr:239:315693
Datum objave publikacije2018
URL dokumentahttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162798/
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2019-11-11 14:01:26